Search by Drug Name or NDC
NDC 47781-0103-33 IBANDRONATE SODIUM 150 mg/1 Details
IBANDRONATE SODIUM 150 mg/1
IBANDRONATE SODIUM is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Alvogen Inc.. The primary component is IBANDRONATE SODIUM.
MedlinePlus Drug Summary
Ibandronate is used to prevent and treat osteoporosis (a condition in which the bones become thin and weak and break easily) in women who have undergone menopause (''change of life,'' end of menstrual periods). Ibandronate is in a class of medications called bisphosphonates. It works by preventing bone breakdown and increasing bone density (thickness).
Related Packages: 47781-0103-33Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Ibandronate
Product Information
| NDC | 47781-0103 |
|---|---|
| Product ID | 47781-103_a9a34956-2167-670a-da19-9fa3689b09b1 |
| Associated GPIs | 30042048100360 |
| GCN Sequence Number | 058915 |
| GCN Sequence Number Description | ibandronate sodium TABLET 150 MG ORAL |
| HIC3 | P4L |
| HIC3 Description | BONE RESORPTION INHIBITORS |
| GCN | 24444 |
| HICL Sequence Number | 017291 |
| HICL Sequence Number Description | IBANDRONATE SODIUM |
| Brand/Generic | Generic |
| Proprietary Name | IBANDRONATE SODIUM |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | IBANDRONATE SODIUM |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 150 |
| Active Ingredient Units | mg/1 |
| Substance Name | IBANDRONATE SODIUM |
| Labeler Name | Alvogen Inc. |
| Pharmaceutical Class | Bisphosphonate [EPC], Diphosphonates [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA078998 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 47781-0103-33 (47781010333)
| NDC Package Code | 47781-103-33 |
|---|---|
| Billing NDC | 47781010333 |
| Package | 3 BLISTER PACK in 1 BOX (47781-103-33) / 1 TABLET in 1 BLISTER PACK (47781-103-07) |
| Marketing Start Date | 2014-05-01 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 5.97889 |
| Pricing Unit | EA |
| Effective Date | 2022-06-22 |
| NDC Description | IBANDRONATE SODIUM 150 MG TAB |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2022-06-22 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis